NASDAQ : FBLG
FibroBiologics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.93 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 6.47M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 8.53M | 9.24M | 9.23M | 6.52M | 3.32M | 1.06M |
| Research & Development | 8.20M | 7.41M | 4.50M | 2.37M | 1.15M | 521.00K |
| Operating Expenses | 16.73M | 16.65M | 13.74M | 8.89M | 4.47M | 1.58M |
| Operating Income | -16.73M | -16.65M | -13.74M | -8.89M | -4.47M | -1.58M |
| Interest Expense | -215.00K | -204.00K | -20.00K | -147.00K | -654.00K | -4.00K |
| Interest & Investment Income | 133.00K | 247.00K | 251.00K | |||
| Other Non Operating Income (Expenses) | -1.33M | -2.04M | 2.35M | -7.45M | ||
| Pretax Income | -18.14M | -18.65M | -11.16M | -16.48M | -5.12M | -1.58M |
| Net Income | -18.14M | -18.65M | -11.16M | -16.48M | -5.12M | -1.58M |
| Preferred Dividends & Other Adjustments | 2.57M | |||||
| Net Income to Common | -18.14M | -18.65M | -11.16M | -19.06M | -5.12M | -1.58M |
| Shares Outstanding (Basic) | 3.81M | 2.23M | 1.64M | 1.41M | 1.41M | 437.50K |
| Shares Outstanding (Diluted) | 3.81M | 2.23M | 1.64M | 1.41M | 1.41M | 437.50K |
| EPS (Basic) | -4.77 | -8.35 | -6.79 | -13.50 | -3.63 | -3.62 |
| EPS (Diluted) | -4.77 | -8.35 | -6.79 | -13.50 | -3.63 | -3.62 |
| Free Cash Flow | -14.80M | -16.66M | -12.09M | -6.90M | -4.07M | -1.41M |
| Free Cash Flow Per Share | -3.89 | -7.46 | -7.35 | -4.88 | -2.88 | -3.22 |
| EBITDA | -16.47M | -16.41M | -13.58M | -8.84M | ||
| D&A For EBITDA | 263.00K | 244.00K | 157.00K | 47.00K | ||
| EBIT | -16.73M | -16.65M | -13.74M | -8.89M | -4.47M | -1.58M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.52M | 4.89M | 13.98M | 9.16M | 2.27M | 407.00K |
| Cash & Short-Term Investments | 3.52M | 4.89M | 13.98M | 9.16M | 2.27M | 407.00K |
| Receivables | 400.00K | 300.00K | ||||
| Prepaid Expenses | 528.00K | 1.46M | 225.00K | 36.00K | 29.00K | 37.00K |
| Other Current Assets | 18.00K | 16.00K | 30.00K | 24.00K | ||
| Total Current Assets | 5.85M | 6.35M | 14.23M | 9.21M | 2.62M | 468.00K |
| Property, Plant & Equipment | 2.03M | 3.22M | 2.22M | 2.61M | 2.20M | |
| Other Long-Term Assets | 48.00K | 48.00K | ||||
| Total Assets | 7.93M | 9.62M | 16.45M | 11.82M | 4.82M | 468.00K |
| Accounts Payable | 1.82M | 945.00K | 2.70M | 1.44M | 758.00K | 233.00K |
| Short-Term Debt | 124.00K | 9.17M | 5.45M | 1.52M | ||
| Current Portion of Leases | 258.00K | 706.00K | 401.00K | 362.00K | 326.00K | |
| Other Current Liabilities | 10.00K | 108.00K | 460.00K | 7.38M | 538.00K | |
| Total Current Liabilities | 2.21M | 1.76M | 12.73M | 9.18M | 7.07M | 1.76M |
| Long-Term Leases | 1.08M | 1.70M | 984.00K | 1.39M | 1.75M | |
| Total Liabilities | 3.29M | 3.46M | 13.71M | 10.57M | 8.82M | 1.76M |
| Common Stock | 1.00K | 1.00K | 1.00K | 1.00K | ||
| Additional Paid-In Capital | 67.92M | 60.32M | 38.25M | 25.61M | 2.41M | |
| Retained Earnings | -63.28M | -54.16M | -35.52M | -24.36M | -7.87M | -2.75M |
| Comprehensive Income & Other | 1.46M | 1.46M | ||||
| Shareholders' Equity | 4.64M | 6.16M | 2.73M | 1.25M | -4.00M | -1.29M |
| Total Liabilities & Equity | 7.93M | 9.62M | 16.45M | 11.82M | 4.82M | 468.00K |
| Total Debt | 1.46M | 2.41M | 10.55M | 1.75M | 7.52M | 1.52M |
| Net Cash (Debt) | 2.05M | 2.48M | 3.43M | 7.42M | -5.26M | -1.12M |
| Net Cash Per Share | 0.54 | 1.11 | 2.09 | 5.25 | -3.73 | -2.56 |
| Filing Date Shares Outstanding | 6.66M | 3.38M | 1.89M | 1.62M | 28.23M | 40.73M |
| Total Common Shares Outstanding | 6.08M | 3.33M | 1.75M | 28.23M | 28.23M | 40.73M |
| Working Capital | 3.64M | 4.59M | 1.50M | 32.00K | -4.45M | -1.29M |
| Book Value Per Share | 0.76 | 1.85 | 1.56 | 0.04 | -0.14 | -0.03 |
| Tangible Book Value | 4.64M | 6.16M | 2.73M | 1.25M | -4.00M | -1.29M |
| Tangible Book Value Per Share | 0.76 | 1.85 | 1.56 | 0.04 | -0.14 | -0.03 |
| Machinery | 1.29M | 1.29M | 1.03M | 844.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -18.14M | -18.65M | -11.16M | -16.48M | -5.12M | -1.58M |
| Depreciation & Amortization | 863.00K | 832.00K | 573.00K | 437.00K | 94.00K | |
| Other Amortization | 625.00K | 81.00K | 389.00K | |||
| Stock-Based Compensation | 2.81M | 2.69M | 2.22M | 1.76M | 265.00K | |
| Other Operating Activities | 1.21M | 1.42M | -4.09M | 7.31M | ||
| Change in Accounts Payable | 20.00K | -1.50M | 1.25M | 671.00K | 525.00K | 233.00K |
| Change in Other Net Operating Assets | -1.55M | -1.81M | -694.00K | -178.00K | -218.00K | -61.00K |
| Operating Cash Flow | -14.79M | -16.39M | -11.90M | -6.40M | -4.07M | -1.41M |
| Capital Expenditures | -6.00K | -262.00K | -184.00K | -495.00K | ||
| Investing Cash Flow | -6.00K | -262.00K | -184.00K | -495.00K | ||
| Short-Term Debt Issued | 4.38M | 9.97M | 4.30M | 2.27M | ||
| Total Debt Issued | 327.00K | 4.38M | 9.97M | 4.30M | 2.27M | |
| Short-Term Debt Repaid | -3.40M | -574.00K | -225.00K | -750.00K | ||
| Total Debt Repaid | -3.60M | -3.40M | -574.00K | -225.00K | -750.00K | |
| Net Debt Issued (Repaid) | -3.28M | 975.00K | 9.40M | 4.08M | 1.52M | |
| Issuance of Common Stock | 10.16M | 6.59M | 7.51M | 292.00K | ||
| Other Financing Activities | 2.58M | -2.35M | -300.00K | |||
| Financing Cash Flow | 9.47M | 7.57M | 16.91M | 13.79M | 5.92M | 1.82M |
| Net Cash Flow | -5.33M | -9.09M | 4.82M | 6.90M | 1.86M | 407.00K |
| Free Cash Flow | -14.80M | -16.66M | -12.09M | -6.90M | -4.07M | -1.41M |
| Free Cash Flow Per Share | -3.89 | -7.46 | -7.35 | -4.88 | -2.88 | -3.22 |
| Levered Free Cash Flow | -8.37M | -9.97M | -11.85M | 3.97M | -1.69M | |
| Unlevered Free Cash Flow | -8.23M | -10.47M | -11.83M | 3.98M | -1.67M | |
| Cash Interest Paid | 206.00K | 204.00K | 20.00K | 2.00K | ||
| Change in Working Capital | -1.53M | -3.31M | 559.00K | 493.00K | 307.00K | 172.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 6.47M | 14.96M | 70.17M | |||
| Enterprise Value | 4.42M | 17.21M | 63.91M | |||
| Last Close Price | 0.93 | 4.50 | 40.00 | |||
| PB Ratio | 1.22 | 2.43 | 25.66 | |||
| P/TBV Ratio | 1.40 | 2.43 | 25.66 | |||
| Debt / Equity Ratio | 0.32 | 0.39 | 3.86 | 1.39 | -1.88 | -1.18 |
| Net Debt / Equity Ratio | -0.44 | -0.40 | -1.25 | -5.92 | -1.32 | -0.87 |
| Net Debt / EBITDA Ratio | 0.12 | 0.15 | 0.25 | 0.84 | ||
| Net Debt / FCF Ratio | 0.14 | 0.15 | 0.28 | 1.07 | -1.29 | -0.79 |
| Quick Ratio | 1.59 | 2.78 | 1.10 | 1.00 | 0.32 | 0.23 |
| Current Ratio | 2.64 | 3.61 | 1.12 | 1.00 | 0.37 | 0.27 |
| Return on Equity (ROE) | -660.08% | -419.44% | -559.73% | |||
| Return on Assets (ROA) | -95.77% | -79.85% | -60.75% | -66.75% | -105.51% | |
| Return on Capital Employed (ROCE) | -292.70% | -211.80% | -369.40% | -337.00% | 198.60% | 122.30% |
| Earnings Yield | -512.43% | -124.64% | -15.90% | |||
| FCF Yield | -228.70% | -111.34% | -17.22% | |||
| Buyback Yield / Dilution | -112.97% | -35.85% | -16.45% | -222.64% |